about
Emilin1 links TGF-beta maturation to blood pressure homeostasisProtein kinase Cθ is required for cardiomyocyte survival and cardiac remodeling.Lack of kinase-independent activity of PI3Kγ in locus coeruleus induces ADHD symptoms through increased CREB signaling.Hemorrhagic transformation of acute ischemic stroke is limited in hypertensive patients with cardiac hypertrophy.PI3Kγ Inhibition Protects Against Diabetic Cardiomyopathy in Mice.Nitric oxide mechanisms of nebivolol.Cardiac overexpression of melusin protects from dilated cardiomyopathy due to long-standing pressure overload.Resistin impairs insulin-evoked vasodilation.Pressure-induced vascular oxidative stress is mediated through activation of integrin-linked kinase 1/betaPIX/Rac-1 pathway.Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway.Increased basal nitric oxide release despite enhanced free radical production in hypertension.Left ventricular hypertrophy is associated with asymptomatic cerebral damage in hypertensive patients.Cooperation between insulin and leptin in the modulation of vascular tone.Mechanisms of soluble beta-amyloid impairment of endothelial function.Tumor necrosis factor-alpha mediates hemolysis-induced vasoconstriction and the cerebral vasospasm evoked by subarachnoid hemorrhage.Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.Beta-amyloid deposition in brain is enhanced in mouse models of arterial hypertension.Effect of stress on hippocampal nociceptin expression in the rat.Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation.PI3Kγ inhibition reduces blood pressure by a vasorelaxant Akt/L-type calcium channel mechanismPI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent EffectsAssessment of the antihypertensive efficacy of various doses of delapril by office and ambulatory blood pressure measurement: The DEFIND studyCharacterization of Nitric Oxide Release by Nebivolol and Its MetabolitesErythrocyte-derived depressing factor: a novel cardiovascular player?MiR-153/Kv7.4: a novel molecular axis in the regulation of hypertension
P50
Q24307505-39808817-B57C-4B52-BFA7-94B9AE635A2AQ34545363-B8B04335-EB97-4861-99FC-57850471855FQ35604751-7B70A679-C617-46DD-9E32-8F41737E14C8Q36063305-400A0BCC-F71D-4674-90E0-D4D3841BBCCCQ36079157-82730F42-692D-48A8-8F18-A3A21703EB8CQ37483065-94E2A10A-DAEA-4D94-BEEC-D6D72CEF84FBQ42477557-1CA5BD4E-65E7-4967-8DF0-E7BC32E50286Q42522267-6A0FBC19-EE75-4FAC-8591-7D20EC1D9152Q43273401-139DB2F0-A02B-4495-B3B6-4DC840B79914Q43833573-C8011BC6-2D83-4D86-B95C-AB972A1DB4EAQ44002456-F794DC2D-116B-4435-BC7C-D218FAFBBFC7Q44477417-5331F096-DAB6-4C44-96FE-31BE608524F1Q44497644-94EC2E9F-7E0D-4C69-9D74-4F5CBE045CF8Q45023573-D9036B99-87AD-4FDC-B1A2-6F77AD5822FDQ45995798-E19C7C44-259B-4300-8D88-B19DA52706A4Q46438566-A791AA53-FAA3-4872-AF9F-8D77299DC5DEQ48087176-0F341F82-CA0F-4D49-8160-9AE73D5D8ED5Q50983647-E4C8B6EE-A95F-4B60-944E-918B828459CAQ54323997-0273631C-4B25-4449-90E6-35C54BF796D7Q57005928-93AAC0AC-E71C-4CC6-91EF-905C2C26B1C7Q57006372-800B7558-B16A-4478-94CF-28F4BA097099Q60647417-696D038A-C17C-4EE4-B334-16F7A7F0210BQ60647418-680BABE6-60FD-46DF-BA8B-81AA6F26E898Q73459990-C9C9ECCD-6B8A-4DAA-B828-BCB13E0902D8Q88344487-0C443646-8704-4446-A4B5-BC969CAFEC4C
P50
description
researcher ORCID ID = 0000-0002-7491-0344
@en
wetenschapper
@nl
name
Angelo Maffei
@ast
Angelo Maffei
@en
Angelo Maffei
@es
Angelo Maffei
@nl
type
label
Angelo Maffei
@ast
Angelo Maffei
@en
Angelo Maffei
@es
Angelo Maffei
@nl
prefLabel
Angelo Maffei
@ast
Angelo Maffei
@en
Angelo Maffei
@es
Angelo Maffei
@nl
P106
P21
P31
P496
0000-0002-7491-0344